中国当代医药
中國噹代醫藥
중국당대의약
PERSON
2014年
32期
20-21,24
,共3页
局部切除术%十二指肠乳头肿瘤%影响因素
跼部切除術%十二指腸乳頭腫瘤%影響因素
국부절제술%십이지장유두종류%영향인소
Local excision%Duodenal tumor%Influence factor
目的:探讨局部切除术治疗十二指肠乳头肿瘤的影响因素。方法选取2007年5月~2009年4月本院收治的40例十二指肠乳头肿瘤患者,收集所有患者的临床资料,通过比较两组患者的生存时间评定两组临床疗效。结果十二指肠乳头肿瘤采用局部切除术治疗后生存时间与术后化疗、肿瘤分化程度、肿瘤直径大小、是否合并十二指肠肠壁浸润、有无淋巴结转移及是否侵犯胰腺有关,差异有统计学意义(P<0.05)。结论局部切除术治疗十二指肠乳头肿瘤的临床疗效与术后化疗、肿瘤分化程度、肿瘤直径大小、是否合并十二指肠肠壁浸润、有无淋巴结转移及是否侵犯胰腺有关,与患者年龄、性别、术前胆红素水平、术前CA19-9水平及术后有无并发症无关。
目的:探討跼部切除術治療十二指腸乳頭腫瘤的影響因素。方法選取2007年5月~2009年4月本院收治的40例十二指腸乳頭腫瘤患者,收集所有患者的臨床資料,通過比較兩組患者的生存時間評定兩組臨床療效。結果十二指腸乳頭腫瘤採用跼部切除術治療後生存時間與術後化療、腫瘤分化程度、腫瘤直徑大小、是否閤併十二指腸腸壁浸潤、有無淋巴結轉移及是否侵犯胰腺有關,差異有統計學意義(P<0.05)。結論跼部切除術治療十二指腸乳頭腫瘤的臨床療效與術後化療、腫瘤分化程度、腫瘤直徑大小、是否閤併十二指腸腸壁浸潤、有無淋巴結轉移及是否侵犯胰腺有關,與患者年齡、性彆、術前膽紅素水平、術前CA19-9水平及術後有無併髮癥無關。
목적:탐토국부절제술치료십이지장유두종류적영향인소。방법선취2007년5월~2009년4월본원수치적40례십이지장유두종류환자,수집소유환자적림상자료,통과비교량조환자적생존시간평정량조림상료효。결과십이지장유두종류채용국부절제술치료후생존시간여술후화료、종류분화정도、종류직경대소、시부합병십이지장장벽침윤、유무림파결전이급시부침범이선유관,차이유통계학의의(P<0.05)。결론국부절제술치료십이지장유두종류적림상료효여술후화료、종류분화정도、종류직경대소、시부합병십이지장장벽침윤、유무림파결전이급시부침범이선유관,여환자년령、성별、술전담홍소수평、술전CA19-9수평급술후유무병발증무관。
Objective To investigate the influence factor analysis of local excision in the treatment of duodenal tumor. Methods 40 patients with duodenal tumor treated in our hospital from May 2007 to April 2009 were collected and the clinical data of all patients were analyzed.Clinical effect of two groups was evaluated by survival time of two groups was compared. Results The survival time after local excision treatment for duodenal tumor were related with postoperative chemotherapy,tumor differentiation,tumor size,whether the merger duodenum bowel wall invasion,whether lymph node metastasis,whether violation of the pancreas,with statistical difference(P<0.05). Conclusion The clinical efficacy of local excision in the treatment of duodenal tumor has relationship with postoperative chemotherapy,tumor differentiation,tu-mor size,whether the merger duodenum bowel wall invasion,whether lymph node metastasis,whether violation of the pancreas,has nothing to do with patient’s age,gender,preoperative bilirubin level,preoperative CA19-9 level,with and without postoperative complication.